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Abstract: Studies on production of secondary metabolites by fungi have received a 
substantial boost lately, particularly with reference to applications of their biological 
properties in human medicine. Funicones represent a series of related compounds for 
which there is accumulating evidence supporting their possible use as pharmaceuticals. 
This paper provides a review on the current status of knowledge on these fungal extrolites, 
with special reference to aspects concerning their molecular structures and   
biological activities. 
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1. Introduction 
 
Starting with the discovery of funicone [1], a series of structurally related compounds have been 
found to be produced by a number of fungal species, particularly within the anamorphic genus 
Penicillium, which is quite famous for its production of antibiotics and other compounds that have 
undergone development as pharmaceuticals. The observation of notable biological properties has 
recently increased the interest of researchers in finding new sources and structural variants of this 
extrolite, whose occurrence within more or less closely related species may also provide useful 
information with reference to chemotaxonomic implications. Aspects concerning production, 
characterization and biological activity of funicone-related compounds are reviewed in this paper. 
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Figure 1. Molecular structures of funicone-related compounds. 
 
 
2. Molecular Structures and Producing Species 
 
The structures of funicone-related compounds (Figure 1) are based on a -pyrone ring which is 
linked through a keto function to a -resorcylic acid nucleus whose carboxylic group is esterified by 
methanol; depending on the specific metabolite, one or more hydroxyl groups may be methylated, Int. J. Mol. Sci. 2009, 10                 
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while several substitutions occur at the carbon atoms of the -pyrone nucleus. The parent molecule of 
the series is funicone (1) [benzoic acid, 2-[[5-hydroxy-4-oxo-6-(1E)-1-propenyl-4H-pyran-3-
yl]carbonyl]-3,5-dimethoxy, methyl ester] [1], which was named after the Latin name of the producing 
organism, Penicillium funiculosum, a species belonging to the subgenus Biverticillium [2]. However, 
considering its description and morphological appearance [3], the producing strain should probably be 
more correctly ascribed to Penicillium pinophilum, a species that was later neotipified and separated 
by P. funiculosum [4]. The compound has been more recently detected in a strain of Talaromyces 
flavus [5], an ascomycetous mycoparasite (Eurotiomycetes, Eurotiales) whose anamorphic state 
(Penicillium dangeardii, syn. P. vermiculatum) is taxonomically closely related to species in the 
subgenus Biverticillium, and in Penicillium simplicissimum (subgenus Furcatum) [6]. 
Some funicone-related products differ by just one or few substitutions on this fundamental 
molecular frame. This is the case of isofunicone (2), a structural isomer produced by an unidentified 
Penicillium strain [7], in which a methoxyl group on the aryl moiety is interchanged with the hydroxyl 
group on the -pyrone nucleus. The latter is absent in deoxyfunicone (3), characterized in two different 
unidentified  Penicillium isolates [8,9], and later also detected in T. flavus [10] and Penicillium 
citreonigrum (teleomorph Eupenicillium euglaucum, subgenus Aspergilloides) [11]. Conversely, the 
hydroxyl group is methylated in 3-O-methylfunicone (4), produced by a soil strain of P. pinophilum 
[12]. Small amounts of the latter substance (funicone methyl ether) had been previously obtained 
synthetically by treating funicone with excess diazomethane in dichloromethane [1]. 
Substitutions concerning the propenyl tail occur in other compounds. In actofunicone (5), again 
isolated from T. flavus [10], this function is replaced by an acetoxypropyl residue, while it is 
substituted by a methyl group in rapicone (6), produced by the anamorphic species Ramichloridium 
apiculatum, an antagonist of plant pathogenic fungi known as powdery mildews (Erysiphaceae) that is 
taxonomically unrelated to Penicillium [13]. Derivatives bearing an epoxide function on the γ-pyrone 
ring (7-8) have been found for both 3-O-methylfunicone [14] and deoxyfunicone [5], respectively, 
from strains of P. pinophilum and T. flavus; as the latter compound is actually an isomer of funicone, it 
may represent a possible intermediate in its biosynthesis. 
Vermistatin (9) [1(3H)-isobenzofuranone, 4,6-dimethoxy-3-[4-oxo-6-[(1E)-1-propen-1-yl-4H-
pyran-3-yl], (3R)], produced by T. flavus [5,10,15-17], presents a slightly more complex molecular 
structure where it can be supposed that, after being reduced, the ketide group interposed between the 
two subunits reacted with the carboxymethyl function of the resorcylic nucleus, to give a 
benzophthalide moiety that has some relevance for the biological activity of the compound. The same 
molecule has been later extracted and characterized under the name of fijiensin by Mycosphaerella 
fijiensis, an ascomycetous fungus (Dothideomycetes, Capnodiales) known as the agent of ‘black 
sigatoka’, a destructive disease of banana plantations [18]. More recently production of vermistatin has 
been documented by another biverticillate species, Penicillium verruculosum [19], by the already 
mentioned P. simplicissimum [6] and P. citreonigrum [11], and by the novel species Talaromyces 
thailandiasis [20]. Finally, its finding as an extrolite of an endophytic ascomycetous strain, isolated by 
a mangrove (Kandelia candel) in Hong Kong and identified as Guignardia sp. (Dothideomycetes, 
Botryosphaeriales) [21], confirms that the biosynthetic ability by fungi for this particular compound is 
possibly even more widespread than currently known. Vermistatin is often extracted together with 
some derivatives, such as hydroxy- and methoxyvermistatin (10-11) [21], 6-demethylvermistatin (12) Int. J. Mol. Sci. 2009, 10                 
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[22], dihydrovermistatin (13), hydroxy- and acetoxy-dihydrovermistatin (14-15), and penisimplicissin 
(16) [6,20]; in analogy with the difference occurring between funicone and rapicone, the latter presents 
a methyl group replacing the propenyl tail. It is interesting to note that another variant corresponding 
to a dihydro-derivative of compound (10), was also artificially obtained by acid reduction of funicone 
under zinc catalysis, possibly in consequence of the conversion of the ortho carbonyl to a secondary 
alcohol and ensuing ring closure with formation of the phthalide lactone [1]. This finding provides 
evidence that vermistatins may be elaborated by enzymes working on precursors with a   
funicone skeleton. 
Merlini et al. [1] consider biosynthesis of funicone to occur following a polyketide pathway through 
a hypothetical tricyclic intermediate. This opinion is shared for the formation of deoxyfunicone [8] and 
rapicone [13], in the latter case by considering analogies with other fungal heptaketides. Actually, the 
presence in the culture filtrates of different strains of T. flavus of other polyketides possibly sharing 
part of a common biosynthetic pathway, such as vermiculin, vermiculinic acid and compound NG-012 
[10,23], corroborates this assumption. However, the finding of 2-methyl-4-hydroxybenzoic acid 
(Figure 2), particularly abundant in the mycelial cake developed in liquid cultures of P. pinophilum, 
has stimulated a hypothesis that 3-O-methylfunicone could rather be directly assembled by two 
molecules of such compound undergoing oxidation [24]. Reactions carried out in artificial conditions 
[25] indicate that another possible precursor involved in the biosynthesis of the γ-pyrone moiety of 
funicones is kojic acid (Figure 2), a compound that is also reported as a fungal extrolite, particularly in 
Penicillium and Aspergillus species [26,27]. 
 
Figure 2. Molecular structures of two possible precursors of funicone-related compounds. 
 
 
Very recently, another series of funicone-related alkaloids has been extracted from semi-solid 
cultures of an endophytic Penicillium strain recovered from Quercus variabilis, whose morphological 
description corresponds to a biverticillate species related but not identical to either P. pinophilum or P. 
verruculosum. Penicidones A-B-C (17-18-19) are structural analogues of vermistatin, 6-demethyl-
vermistatin and deoxyfunicone, respectively, in which the heterocyclic moiety consists of a quite 
unusual  -pyridone nucleus [28], that to our knowledge can be only found in another series of 
Penicillium extrolites, the citridones [29]. It is thought that the N atom in the pyridone ring could 
originate from glutamate under the catalysis of aminotransferase [28], but pyridones have been also 
synthesized as hydrophilic derivatives of kojic acid [27]. Moreover, a pyridone variant was also 
artificially obtained by hydroxy-dihydrovermistatin reacting with methylamine in methanol [1]. 
Therefore, the evidence is strong that penicidones and funicones be synthesized through a common 
biosynthetic pathway. 
 Int. J. Mol. Sci. 2009, 10                 
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Table 1. Main physico-chemical features of funicone-related compounds. 
Compound Formula  Mol.  weight  Melting point (°C)  UV absorbance (nm) 
Acetoxy-dihydrovermistatin C20H20O8 388.1160  undetermined  210,  246,  305 
Actofunicone C21H22O9 418.1264  -  208,  246,  316 
6-Demethylvermistatin C17H14O6 314.0787  195-196   
Deoxyfunicone C19H18O7 358.1053  127.5-128.5  220,  249,  314 
14,15-Dihydrovermistatin C18H18O6 330.1103  143-145  210,  245,  303 
9,14-Epoxy-11-deoxyfunicone C19H18O8 374.0975  166-167  203,  282 
Funicone C19H18O8 374.1004  176-178  245,  310,  368 
Hydroxy-dihydrovermistatin C18H18O7 346.1064  184-185  210,  248,  306 
Hydroxyvermistatin C18H16O7 344.0887  226-227   
Isofunicone C19H18O8 374.1004  215-218  249,  285,  293 
Methoxyvermistatin C19H18O7 358.1053  198-199   
3-O-Methyl-5,6-epoxyfunicone C20H20O9 404.1107  undetermined  210,  312 
3-O-Methylfunicone C20H20O8 388.1160  185-187  249,  293 
Penicidone A  C18H18NO5 328.1179  undetermined  206, 237 
Penicidone B  C17H16NO5 314.1023  undetermined  209, 239 
Penicidone C  C19H20NO6 358.1285  undetermined  215, 253 
Penisimplicissin C16H14O6 302.0790  185-186  210,  247,  305 
Rapicone C17H16O7 332.0896  162-163  244,  314 
Vermistatin C18H16O6 328.0950  213-214  210,  262,  302 
 
Funicone-related compounds represent a homogeneous group of fungal metabolites sharing a 
number of physico-chemical features (Table 1). They are water insoluble, therefore readily extracted 
by most organic solvents, with the exception of n-hexane; they confer a yellow color to the solution, 
while appearing as white or pale yellow powders when dried. An exception is represented by 
actofunicone, that is the only member of the series possessing an oily consistency at room temperature. 
Melting points of the other products are in a range between 128°C (deoxyfunicone) and 227°C 
(hydroxyvermistatin). The presence of an aromatic ring highly conjugated with the double bonds of the 
γ-pyrone moiety is responsible for UV-absorbance, whose values can be relevant in view of a rapid 
detection in the culture extracts. 
 
3. Methodology for Production and Extraction of Funicone-Related Compounds 
 
Besides the previously mentioned analogy existing between the penicidones and three ‘pyronic’ 
funicones, by considering the fundamental difference in the aryl moieties of funicone and vermistatin 
it results that substitutions occurring at the γ-pyrone ring generate several pairs of corresponding 
analogues. This is the case of funicone and hydroxyvermistatin, deoxyfunicone and vermistatin, 3-O-
methylfunicone and methoxyvermistatin, rapicone and penisimplicissin. It may be questionable if 
some of these variants are eventually artefacts ensuing treatment with organic solvents, particularly 
methanol. Actually, the fact that they can be recovered by different strains and by means of different 
methodologies for extraction and purification seems to contradict such a hypothesis. However, as 
conditions for culturing the fungal strains and/or the extraction of culture filtrates may somehow 
influence the biosynthetic process and/or the recovery of the fermentation products, it is quite Int. J. Mol. Sci. 2009, 10                 
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important to consider these aspects by comparing the procedures followed for each compound of  
the series. 
Information concerning composition of the substrates used for culturing the producing strains is 
provided in the appendix, while growth parameters are summarized in Table 2, together with 
conditions for extraction and purification. The fact that these compounds are produced on a variety of 
substrates, more or less rich in nutrients, indicates that their production is possibly constitutive rather 
than being induced by particular carbon sources or other components.  
 
Table 2. Conditions for production, extraction and purification of funicone- 
related compounds. 
Compound Species 
Refe-
rence 
Substrate * 
Conditions of 
growth 
Extraction Purification 
Acetoxy-
dihydrovermistatin 
P. simplicissimum  6  Moist rice  21 d, 25°C  CH2Cl2-MeOH; EtOAc  CC; LPLC; HPLC 
Actofunicone  T. flavus  10  Medium E  5 d, 27°C, AG  Me2CO; EtOAc  MPLC; HPLC 
6-Demethylvermistatin  Guignardia sp.  22  Medium F1  25 d, 28°C  EtOAc  CC 
Deoxyfunicone  Penicillium sp. 
Penicillium sp. 
T. flavus 
8 
9 
10 
Medium C 
AD2 
Medium E 
6 d, 25°C, AG 
21 d, 22°C, AG 
5 d, 27°C, AG 
EtOAc 
MeEtCO 
Me2CO; EtOAc 
CC 
CC; HPLC; TLC 
MPLC; HPLC 
14,15-Dihydroverm-
istatin 
P. simplicissimum 
E. euglaucum 
6 
11 
Moist rice 
Wickerham 
21 d, 25°C 
21 d, RT 
CH2Cl2-MeOH; EtOAc 
EtOAc 
CC; LPLC; HPLC 
CC 
9,14-Epoxy-11-deoxy-
funicone 
T. flavus  5  Moist barley grains  21 d, 25°C  CH2Cl2-MeOH; EtOAc  CC; LPLC 
Funicone  P. funiculosum (?) 
T. flavus 
P. simplicissimum 
3 
5 
6 
Medium A 
Moist barley grains 
Moist rice 
4 d 
21 d, 25°C 
21 d, 25°C 
Et2O 
CH2Cl2-MeOH; EtOAc 
CH2Cl2-MeOH; EtOAc 
TLC 
CC; LPLC 
CC; LPLC; HPLC 
Hydroxy-
dihydrovermistatin 
P. simplicissimum 
T. thailandiasis 
6 
20 
Moist rice 
Moist rice 
21 d, 25°C 
30 d, 28°C 
CH2Cl2-MeOH; EtOAc 
EtOAc; CHCl3 
CC; LPLC; HPLC 
CC 
Hydroxyvermistatin  Guignardia sp.  21  Medium F  30 d, RT  EtOAc  CC; TLC 
Isofunicone  Penicillium sp.  7  Medium D  21 d, 24°C, ST  EtOAc  CC 
Methoxyvermistatin  P. simplicissimum 
Guignardia sp. 
6 
21 
Moist rice 
Medium F 
21 d, 25°C 
30 d, RT 
CH2Cl2-MeOH; EtOAc 
EtOAc 
CC; LPLC; HPLC 
CC 
3-O-Methyl-5,6-
epoxyfunicone 
P. pinophilum  14  PDB  21 d, 25°C, ST  CH3Cl; Me2CO-MeOH TLC 
3-O-Methylfunicone  P. pinophilum  12  PDB  21 d, 25°C, ST  CH3Cl; Me2CO-MeOH TLC 
Penicidones  Penicillium sp.  28  Medium G  20 d, 28°C  MeOH; EtOAc  CC 
Penisimplicissin  P. simplicissimum 
T. thailandiasis 
6 
20 
Moist rice 
Moist rice 
21 d, 25°C 
30 d, 28°C 
CH2Cl2-MeOH; EtOAc 
EtOAc; CHCl3 
CC; LPLC; HPLC 
CC 
Rapicone  R. apiculatum  13  PDB  21 d, 28°C, ST  CH2Cl2 CC;  LPLC Int. J. Mol. Sci. 2009, 10                 
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Table 2. Cont. 
Compound Species 
Refe-
rence 
Substrate * 
Conditions of 
growth 
Extraction Purification 
Vermistatin  T. flavus 
 
 
 
M. fijiensis 
 
P. verruculosum 
P. simplicissimum 
E. euglaucum 
T. thailandiasis 
Guignardia sp. 
15 
17 
10 
5 
18 
 
19 
6 
11 
20 
21 
Medium B 
Czapek-Dox broth 
Medium E 
Moist barley grains 
M-1-D/coconut 
 
Medium H 
Moist rice 
Wickerham 
Moist rice 
Medium F 
5-6 d, 28°C, AG 
30 d, 27°C, AG 
5 d, 27°C, AG 
21 d, 25°C 
28 d, 26°C, AG, 
12h  
17 d, 24°C 
21 d, 25°C 
21 d, RT 
30 d, 28°C 
30 d, RT 
CH2Cl2 
EtOAc 
Me2CO; EtOAc 
CH2Cl2-MeOH; EtOAc 
MeOH; EtOAc 
 
EtOAc 
CH2Cl2-MeOH; EtOAc 
EtOAc 
EtOAc; CHCl3 
EtOAc 
TLC 
CC; TLC 
MPLC; HPLC 
CC; LPLC 
TLC; HPLC 
 
CC 
CC; LPLC; HPLC 
CC 
CC 
CC; TLC 
* also see Appendix. Abbreviations: PDB, potato-dextrose broth; RT, room temperature; AG, cultures 
maintained in agitation; ST, cultures on stationary phase; 12h, 12-hour photoperiod; MeOH, methanol; 
EtOAc, ethyl acetate; Me2CO, acetone; MeEtCO, methyl ethyl ketone; CH2Cl2, dichloromethane; Et2O, 
diethyl ether; CHCl3, chloroform; CC, column chromatography; LPLC, low performance liquid 
chromatography; HPLC, high performance liquid chromatography; MPLC, medium performance liquid 
chromatography; TLC, thin-layer chromatography. 
 
However, specific assays carried out for vermistatin have shown that the nitrogen source and the 
availability of some organic acids, such as malate and succinate, may notably influence the yield 
[30,31], which otherwise basically depends on duration of culturing. In most cases cultures are 
maintained for three weeks or longer, but available data are not sufficient to indicate the most 
appropriate length of the fermentation cycle. Both funicone and deoxyfunicone were initially 
recovered after just 4-6 days of growth of the producing strains [1,8], but their finding as major 
products after prolonged culturing [5,6,9] contrasts the eventuality that they may actually represent 
intermediates in the biosynthesis of other compounds of the series. Funicone was obtained in a 
comparatively higher yield by culturing the producing strain on moist barley grains, and extracting the 
cultures twice: first with a mixture of dichloromethane and methanol (1:1), then with ethyl acetate after 
re-suspending the residue in water [5]; purification of the compound together with small quantities of 
9,14-epoxy-11-deoxyfunicone and vermistatin was achieved by a multi-step chromatographic 
procedure that may be quite helpful with the aim to recover by-products eventually produced in small 
quantities. A more complex methodology leading to the extraction of several analogues [10] consisted 
in a preliminary extraction with acetone, followed by a further extraction with ethyl acetate; the 
resulting oily material was dissolved in methanol and submitted to MPLC eluting with a linear 
gradient from 30% to 80% acetonitrile; the active fractions, containing deoxyfunicone, actofunicone 
and vermistatin, were then purified through HPLC. 
Vermistatin can be also considered a terminal product of the biosynthetic process; in fact, besides 
having been recovered after just 1-week culturing [10,15], most methods provide for its extraction 
after a prolonged fermentation [5,6,11,17,19-21]. In the procedure set up for extraction by M. fijiensis 
[18] the compound could be detected no earlier than 21-24 days, indicating that particular carbon 
sources and the presence of light may depress its biosynthesis. Int. J. Mol. Sci. 2009, 10                 
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4. Biological Activities of Funicone-Related Compounds 
 
So far biological activity of the known funicone-related compounds has not been studied 
comprehensively due to the different objectives pursued by several independent investigators. At first 
funicone did not show any notable biological effects, as it was found to just slightly stimulate rooting 
of tomato sprouts, while assays carried out against Bacillus subtilis and  Staphylococcus aureus 
resulted in quite poor antibiotic properties [3]. More recently, fungitoxicity was observed in assays 
carried out by a paper disc method against the human pathogenic species Aspergillus fumigatus, while 
two yeasts of medical relevance, Candida albicans and Cryptococcus neoformans, were unaffected 
[5]. The same study showed a low fungitoxic activity by 9,14-epoxy-11-deoxyfunicone against 
Aspergillus niger, while the homologous compound 3-O-methyl-5,6-epoxyfunicone was found to be 
inactive against Rhizoctonia solani, Alternaria alternata and Fusarium solani, possibly due to 
structural unstableness [14]. In an in vitro assay developed for screening new potential herbicide 
products, isofunicone inhibited the germination tube of pollen grains of Camellia sinensis at a 
concentration of 10 g/mL [7]. Rather than being phytotoxic, deoxyfunicone showed plant growth 
stimulatory properties on radicles of lettuce and Chinese cabbage seedlings at concentrations between 
10 and 50 g/mL; moreover the compound displayed notable fungitoxicity against Gibberella 
fujikuroi, Pyricularia oryzae and F. solani f.sp. phaseoli, while no antibacterial effect was evident [8]. 
As assayed for insecticidal properties against Lepidoptera larvae (Spodoptera littoralis), both 
deoxyfunicone and vermistatin were inactive, while a very low activity was recorded against Artemia 
salina [11]. A more considerable pharmaceutical application of deoxyfunicone may derive on account 
of the antiviral properties disclosed as a HIV-1-integrase inhibitor [9,32]. 
Consistent fungitoxic properties have been also observed for 3-O-methylfunicone, that suppressed 
in vitro mycelial growth of a number of plant pathogenic fungi, such as R. solani,  A. alternata, 
Cylindrocladium scoparium and F. solani, at a concentration of 100 g/mL [12,33]. The same 
concentration also inhibited dermatophytic species, such as Trichophyton rubrum and Microsporum 
canis, while, as already pointed out for other compounds of the series, it was not effective against C. 
albicans [34]. Antiproliferative properties by 3-O-methylfunicone have later resulted against human 
tumor cell lines. In fact, cytostatic effects and the induction of programmed death were observed on 
HEp-2 cells (derived from larynx carcinoma) at a concentration of 60 g/ml [35]. Results of biological 
assays were quite similar on HeLa cells (cervix-uteri carcinoma), which are arrested at the G1 phase of 
the cell cycle and undergo apoptosis following a p53 independent pathway in consequence of the 
activation of pro-apoptotic genes (p21) whose expression reflects the inhibition of the Cdk4-cyclin D1 
complex [36]. Antiproliferative and pro-apoptotic properties have been also evidenced on other tumor 
cell types derived from lung carcinoma (A549) [37], and melanoma (A375P and A375M), where the 
inhibitory effect on cell cycle progression occurs at the G2 boundary, with a reduction in the 
expression of cyclin B1 and cyclin-dependent kinase p34 [38]. Moreover, the compound has been 
found to inhibit the gene expression of typical markers of tumor progression, such as survivin and 
human telomerase reverse transcriptase (h-TERT), and to strongly affect cell proliferation and motility 
of breast cancer MCF-7 cells by down-regulating αvβ5 integrin and inhibiting matrix 
metalloproteinase (MMP-9) secretion. This effect is selective, as it was not observed on a non-tumor 
breast cell line (MCF-10) [39]. Inhibition of cell motility is also associated to modifications in cell 
shape and in the distribution of tubulin fibers of MCF-7 cells. The latter effect may depend on the tri-Int. J. Mol. Sci. 2009, 10                 
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methoxylated aryl moiety, that brings some funicone compounds in functional analogy with other 
natural products well-known as antitumor pharmaceuticals, such as combretastatin, the 
podophyllotoxins, and the chalcones [40]. 
Some level of cytotoxic activity by a funicone-related compound had been previously demonstrated 
for vermistatin on murine leukemic cells (P388) and Ehrlich ascites, where the compound acts as a 
RNA-synthesis inhibitor [15]. Possible relevance of vermistatin as an antitumor compound has been 
pointed out more recently, after its inhibitory properties were observed against mouse lymphoma cells 
(L5178Y) at a concentration of 10 g/mL; moreover the compound was slightly inhibitory toward 
several kinases, such as aurora A and B, cdk 4/cyclin D1, the insulin-like growth factor receptor-1, 
ErbB2, BRAF-VE, Akt1 and the vascular endothelial growth factor receptor-2, involved in the cell 
cycle progression and apoptosis induction, or implicated in the pathologic angiogenesis associated 
with tumor growth [11]. Otherwise, quite a low biological activity has been reported on different 
organisms, starting with its effects as a banana-specific toxin [18]. As assayed against A. fumigatus and 
A. niger, vermistatin and its derivatives showed almost no antifungal activity [6]. Together with 
actofunicone and deoxyfunicone, it has also proved to be ineffective against C. albicans at 
concentrations up to 300 g/mL; however, these compounds became inhibitory when administered in 
association with myconazole [10]. As this fungicide is frequently ineffective by itself on 
immunocompromised patients, the synergistic capacity of funicones to potentiate its efficacy by 5-10 
times provides more indications for their chemotherapeutic potential. Finally, further pharmaceutical 
perspectives of vermistatin can be considered in view of the anxiolytic effects shown by other 
compounds with a benzalphthalide skeleton [41]. Actually, the phthalide moiety seems to be quite 
important for biological activity, as some derivatives obtained by artificial hydrogenation proved to be 
inactive when modifications were introduced in this part of the molecule [42]. However, the inactivity 
observed in the case of dihydrovermistatin [11] suggests that the propenyl tail is also quite relevant to 
this regard. The higher cytotoxic activity of methoxyvermistatin, as measured against KB and KBv200 
cells (derived from epithelial carcinoma) [21], also indicates that a remarkable importance pertains to 
the methoxyl group at the γ-pyrone ring, which also characterizes 3-O-methylfunicone. To this regard, 
it must be considered that the antifungal activity reported for several derivatives of kojic acid [43] 
provides a further indirect evidence that biological properties of funicone-related compounds are in 
part dependent on the γ-pyrone moiety. 
By reason of their very recent discovery, so far penicidones have been just preliminarily assayed for 
inhibitory properties against a few cell lines, such as HeLa, KB, K562 (myeloid leukemia) and 
SW1116 (colon cancer), displaying moderate cytotoxicity [28]; the comparative effects of these 
extrolites and their -pyrone analogues should be more thoroughly considered in order to obtain further 
evidences concerning the active site of funicone-related compounds. 
 
4. Conclusions 
 
As introduced above, the quite notable biological activities of funicone-related compounds put 
forward a perspective for their development as pharmaceuticals. Therefore it is likely that these 
extrolites will be the subject of further investigations for production by fungi in the near future, also 
considering that the finding of a number of analogues in several unrelated species belonging to two Int. J. Mol. Sci. 2009, 10                 
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different classes introduces a possible more widespread occurrence. For the time being most reports 
concern Penicillium species, particularly those ascribed to the subgenus Biverticillium and their related 
Talaromyces teleomorphs [34,44,45]. Therefore, following the consolidated approach established for 
taxonomy of the terverticillate Penicillia (subgenus Penicillium) [46], the increasing amount of data 
gathered within this context is susceptible to be considered for chemotaxonomic purposes, particularly 
in view of attaining to a more accomplished characterization of a number of biverticillate species 
whose taxonomic status is uncertain [4,44,45]. In this regard, methods allowing a rapid analysis of 
fungal extracts, particularly those based on HPLC [11,23,44], are likely to provide a substantial 
contribution for a more considerable detection of these compounds. 
 
Appendix: Synthetic Media Used for Production of Funicone-Related Compounds (Composition 
Per Litre, Except for Semisolid Medium G). 
 
Medium A [3] 
Glucose    40  g 
Ammonium tartrate    4.7 g 
KH2PO4     1.02 g 
MgSO4   0.51 g 
KCl     0.51  g 
FeSO4     0.01 g 
Agar 
 
Medium B [15] 
Glucose    9% 
NaNO3     0.2% 
KH2PO4    0.1% 
MgSO4
.7H2O    0.05% 
KCl     0.05% 
FeSO4
.7H2O    0.001% 
pH = 6.3 
 
Medium C [8] 
Commercial sugar (saccharose ?)  4% 
Corn  steep  liquor    2% 
 
Medium D [7] 
Malt  extract    20  g 
Glucose    50  g 
Peptone    3  g 
 
Medium E [10] 
PDB     2.4% Int. J. Mol. Sci. 2009, 10                 
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Malt  extract    0.5% 
Mg3(PO4)2
.8H2O   0.5% 
Agar     0.1% 
pH = 6.0 
 
Medium F [21] 
Glucose    10  g 
Peptone    2  g 
Yeast  extract    1  g 
NaCl     30  g 
 
Medium F1 [22] 
Glucose    10  g 
Peptone    2  g 
Yeast  extract    1  g 
NaCl     2  g 
pH = 7.0 
 
Medium G [28] 
Grain     7.5  g 
Bran     7.5  g 
Yeast  extract    0.5  g 
Sodium tartrate    0.1 g 
FeSO4
.7H2O    0.01  g 
Sodium glutamate    0.1 g 
Pure corn oil      0.1 mL 
Water     30  mL 
 
Medium H [19] 
Carrot  extract    ? 
Glucose    50  g 
NaNO3     3  g 
KH2PO4    1  g 
MgSO4
.7H2O    0.5  g 
KCl     0.5  g 
FeSO4
.7H2O    0.01  g 
pH = 4.5 
 
AD-2 [9] 
Glucose    150  g 
Glycerol    20  g 
Yeast  extract    4  g Int. J. Mol. Sci. 2009, 10                 
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NaNO3      1  g 
Sodium glutamate     3 g 
Na2HPO4      0.5  g 
MgSO4
.7H2O    1  g 
Trace element solution  1 mL 
CaCO3     8  g 
pH = 7.0 
 
M-1-D/coconut [18] 
Inositol   5  g 
Thiamine    0.5  g 
Biotin     0.5  g 
Coconut  water    12  mL 
 
Wickerham [11] 
Glucose    10  g 
Bacto-peptone    5  g 
Yeast  extract    3  g 
Malt  extract    3  g 
pH = 7.3 
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